openPR Logo
Press release

Insights on the Myasthenia Gravis Treatment Market to 2019 - Advancements in Supply Chain Management, Industry Presents Opportunities, Business Strategy By 2026 | Valeant Pharmaceuticals International, Novartis Pharmaceuticals Corporation, Apotex Corporat

11-30-2021 04:53 AM CET | Health & Medicine

Press release from: StraitsResearch

Myasthenia Gravis Treatment Market

Myasthenia Gravis Treatment Market

Myasthenia Gravis Treatment Market Snapshot:

The global myasthenia gravis treatment market was valued at around USD 1,011.1 million in 2017 and is expected to grow at a CAGR of 12.1% during the forecast period.

According to the Myasthenia Gravis Foundation of America, myasthenia gravis is one of the most common primary disorders of neuromuscular transmission. Around 14 to 20 out of every 100,000 people in the United States suffer from myasthenia gravis. While myasthenia gravis can affect people of all ages, it is more common in women under 40 and men older than 60. According to Elsevier, 1,283 New Zealanders are affected by a neuromuscular disorder, amounting to a collective prevalence of 30.25 cases per 100,000. Growing development of novel drugs such as monoclonal antibodies is driving the growth of the myasthenia gravis treatment market. Moreover, growing awareness regarding treatment and increasing number of clinical facilities are also boosting market growth, globally.

The ocular MG segment is expected to account for a prominent market share, owing to the high prevalence of the disease, the market can be segmented into medication, surgery, Autologous Hematopoietic Stem Cell Transplantation (HSCT), plasmapheresis & intravenous immunoglobulin, and others. Among these, the autologous hematopoietic stem cell transplantation segment is expected to hold a significant market share, owing to the therapy’s cost-effectiveness. Among these, the hospitals segment is expected to hold a noteworthy market share during the forecast period.

North America is expected to hold the largest market share, owing to the increasing number of drug manufacturers and rising awareness about the long-term effects of muscular dystrophy. Moreover, increasing government funding for the treatment of this disease in North America is also favoring market growth. According to National Centers for Advancing Translation Science, in the U.S., around 1 in 500,000 people suffer from disorders each year.

Asia Pacific is expected to be the fastest growing region due to the increasing awareness about neuromuscular disorders and enhancement in healthcare reforms across countries such as Malaysia, India, Indonesia, and China. Apart from this, the increasing geriatric population is supporting market growth on account of the increasing prevalence of the disorder.

Obtain Brochure For Latest Technology Advancements @ 
https://straitsresearch.com/report/myasthenia-gravis-treatment-market/request-sample

The Major Prominent Players Covered in this Report:
Valeant Pharmaceuticals International, Novartis Pharmaceuticals Corporation, Apotex Corporation, Teva Pharmaceutical Industries Ltd., RPG Life Sciences, Cipla, F. Hoffmann Roche La Ltd., Bristol-Myers Squibb Company, Biogen Inc., AbbVie Inc., GlaxoSmithKline plc, and Fresenius Kabi. & More.

By Type
Ocular MG
Congenital MG
Transient Neonatal MG

By Treatment
Medication
Surgery
Autologous Hematopoietic Stem Cell Transplantation (HSCT)
Plasmapheresis & Intravenous Immunoglobulin
Others

By End-User
Hospitals
Clinics
Academic Research Institutes
Others

Growing Domestic Demand and Expanding Pharmaceutical Sector to Drive the Demand for Myasthenia Gravis Treatment in the APAC Region
Asia-Pacific region is anticipated to hold the largest market share in the global Myasthenia Gravis Treatment market during the forecast period 2019-2026. The growth in this region can be attributed to the presence of emerging economies like India, China, Japan, Vietnam, and Indonesia, which account for the largest share in this region. India is one of the largest producers of Myasthenia Gravis Treatment and a major exporter of the product to various countries across the globe. India accounts for around 80% of the world’s exports of Myasthenia Gravis Treatment. The favorable climatic conditions and growth of agricultural inputs and allied services like cold storage and warehousing in India are prompting higher production.

View this report with a detailed description and TOC @ 
https://straitsresearch.com/report/myasthenia-gravis-treatment-market/toc

Key Questions Answered in The Report:
What will the Myasthenia Gravis Treatment market growth rate?
What are the key factors driving the global Myasthenia Gravis Treatment market?
Who are the key manufacturers in the Myasthenia Gravis Treatment market space?
What are the market opportunities, market risk, and market overview of the Myasthenia Gravis Treatment market?
What are sales, revenue, and price analysis of top manufacturers of the Myasthenia Gravis Treatment market?
Who are the distributors, traders, and dealers of the Myasthenia Gravis Treatment market?
What are the market opportunities and threats faced by the vendors in the global Steerable Medical Devices Industry?
What are sales, revenue, and price analysis by types and applications of the Myasthenia Gravis Treatment Industry?
What are sales, revenue, and price analysis by regions of Myasthenia Gravis Treatment industry?
What are the driving factors contributing to market growth during the short, medium, and long term?

Key Myasthenia Gravis Treatment Market Trends:
- The report identifies, determines, and forecasts the Global Myasthenia Gravis Treatment Market segments based on their type, sub-type, technology used, applications, end-users, and regions.
- Industry to Industry Holds Largest Share in the Myasthenia Gravis Treatment Market
- It examines the micro-markets based on their growth trends, development patterns, future prospects, and contribution to the overall market.
- Demand from Regional / geographical is Expected to Drive the Growth
- Rising Adoption of Market Segments in this Growth
- North American, Europe is Expected to Witness Higher Growth Rate over the Forecast Period
- It studies the competitive developments such as partnerships and collaborations, mergers and acquisitions (M&A), research and development (R&D) activities, product developments, and expansions in the Global Myasthenia Gravis Treatment Market.

Key Developments -
In 2018, Teva Pharmaceutical Industries Ltd. launched the generic version of Syprine capsules, 250 mg, in the U.S.

In 2015, Fresenius Kabi introduced the anti-infective Moxifloxacin Injection 400 mg per 250 mL in Freeflex bags.

Report Inclusions -
Historical inferences, findings & analysis of the market for the duration of 2016 to 2018
Projections and performance forecast analysis for the duration of 2019 to 2026
Production and consumption point-of-view (POV) analysis
Market driver, restraint and opportunity analysis to define market dynamics, covering industry, regulatory, innovation, technological, and pricing trends
Comprehensive competitive landscape mapping with recent developments, covering market leadership, competency, sustainability, and future prospects

Browse Full Report @ https://straitsresearch.com/report/myasthenia-gravis-treatment-market/

Even if your business is a multinational venture or a single storefront, we believe innovation is the key to progress, in both what you build and how you promote your products and brands.

Buy Full Report with Detail Analysis with COVID-19 Impact – https://straitsresearch.com/buy-now/myasthenia-gravis-treatment-market/global/

So let's put our minds together. We'll make your vision a reality and help you grow.

For more details, please contact us -
Straits Research
Email: sales@straitsresearch.com
Address: 825 3rd Avenue, New York, NY 10022
Tel: +1 646 480 7505, +44 208 068 9665
Website: https://straitsresearch.com/

About Us:
Regardless of whether you're looking at business sectors in the next town or crosswise over continents, we understand the significance of being acquainted with what customers purchase. We overcome the issues of our customers by recognizing and deciphering just the target group, while simultaneously generating leads with the highest precision. We seek to collaborate with our customers to deliver a broad spectrum of results through a blend of market and business research approaches. This approach of using various research and analysis strategies enables us to determine greater insights by eliminating the research costs.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Insights on the Myasthenia Gravis Treatment Market to 2019 - Advancements in Supply Chain Management, Industry Presents Opportunities, Business Strategy By 2026 | Valeant Pharmaceuticals International, Novartis Pharmaceuticals Corporation, Apotex Corporat here

News-ID: 2478670 • Views:

More Releases from StraitsResearch

Maleic Anhydride Market 2022: Explore Top Factors that Will Boost the Global Market by 2029
Maleic Anhydride Market 2022: Explore Top Factors that Will Boost the Global Mar …
Maleic Anhydride Market The research methodology of Straits Research involves an ideal combination of primary and secondary research with the help of which the experts' inferences and calculations are derived. Our reports are revised at regular intervals to be able to give recent information to our clients and help them make efficient business decisions. The information provided in the reports is verified in terms of quality and reliability. The Major Players Covered in this
Blood Glucose Lancets Market Emerging Technological Growth, Future Growth and Business Opportunities 2029
Blood Glucose Lancets Market Emerging Technological Growth, Future Growth and Bu …
Blood Glucose Lancets Market The research methodology of Straits Research involves an ideal combination of primary and secondary research with the help of which the experts' inferences and calculations are derived. Our reports are revised at regular intervals to be able to give recent information to our clients and help them make efficient business decisions. The information provided in the reports is verified in terms of quality and reliability. The Major Players Covered in
Graphic Film Market: Business Class Seating Type To Rising at 4.6% During 2022-2029
Graphic Film Market: Business Class Seating Type To Rising at 4.6% During 2022-2 …
Graphic Film Market The research methodology of Straits Research involves an ideal combination of primary and secondary research with the help of which the experts' inferences and calculations are derived. Our reports are revised at regular intervals to be able to give recent information to our clients and help them make efficient business decisions. The information provided in the reports is verified in terms of quality and reliability. The Major Players Covered in this
Digital PCR Market to See Wonderful Rise during 2022-2029 with High CAGR Growth
Digital PCR Market to See Wonderful Rise during 2022-2029 with High CAGR Growth
Digital PCR Market The research methodology of Straits Research involves an ideal combination of primary and secondary research with the help of which the experts' inferences and calculations are derived. Our reports are revised at regular intervals to be able to give recent information to our clients and help them make efficient business decisions. The information provided in the reports is verified in terms of quality and reliability. The Major Players Covered in this

All 5 Releases


More Releases for Myasthenia

Myasthenia Gravis Market | Rising Prevalence Of Neuromuscular Disorders
According to Precision Business Insights (PBI), the latest report, the Myasthenia Gravis market is expected to be valued at USD 1,734.6 million in 2022, growing at an 8.1% CAGR from 2022 to 2028. The primary driver of the expansion of the global Myasthenia Gravis market increasing prevalence of neuromuscular disorders, and rising awareness about effective treatment. View the detailed report description here - https://precisionbusinessinsights.com/market-reports/myasthenia-gravis-market/ Medication Segment to Dominate the Myasthenia
Myasthenia Gravis - Drug Pipeline Landscape, 2022
Myasthenia gravis is a chronic autoimmune neuromuscular condition that causes muscle weakness and severe fatigue. It causes weakness in the skeletal muscles, which are the muscles your body uses for movement. Myasthenia gravis is caused by a breakdown in the normal communication between nerves and muscles. Healthcare professional checks neurological health by testing reflexes, muscle strength, muscle tone etc. Ice pack test, antibody tests, imaging scans and electromyogram can also be
Myasthenia Gravis Industry Report Analysis By opportunities
Stratistics MRC's Myasthenia Gravis Market report provides readers with an understanding of market details, overview, drivers and segmentation with types. Myasthenia gravis is a chronic autoimmune neuromuscular disorder that is characterized by variable weakness of the voluntary muscle groups. Muscles that observe eye movement, shoulder & facial muscles, breathing & swallowing and eye lids are the ones that are regularly impacted in myasthenia gravis. Browse complete "Myasthenia Gravis Market" report with TOC
Myasthenia Gravis Industry Report Analysis By opportunities
Stratistics MRC's Myasthenia Gravis Market report provides readers with an understanding of market details, overview, drivers and segmentation with types. Myasthenia gravis is a chronic autoimmune neuromuscular disorder that is characterized by variable weakness of the voluntary muscle groups. Muscles that observe eye movement, shoulder & facial muscles, breathing & swallowing and eye lids are the ones that are regularly impacted in myasthenia gravis. Browse complete "Myasthenia Gravis Market" report with TOC
Global Myasthenia Gravis Industry Analysis By Geography
Stratistics MRC's Myasthenia Gravis Market report explains company profiling, key segments, market trends, top players and regional, country-level segments. Myasthenia gravis is a chronic autoimmune neuromuscular disorder that is characterized by variable weakness of the voluntary muscle groups. Muscles that observe eye movement, shoulder & facial muscles, breathing & swallowing and eye lids are the ones that are regularly impacted in myasthenia gravis. Browse complete "Myasthenia Gravis Market" report with TOC @
Global Myasthenia Gravis Industry Report Top 5 Players
Stratistics MRCs 2021 Myasthenia Gravis Market Report Key players include - Medtronic Plc., Novartis AG, Koninklijke Philips N.V., Pfizer Inc., Baxter International. Myasthenia gravis is a chronic autoimmune neuromuscular disorder that is characterized by variable weakness of the voluntary muscle groups. Muscles that observe eye movement, shoulder & facial muscles, breathing & swallowing and eye lids are the ones that are regularly impacted in myasthenia gravis. Browse complete "Myasthenia Gravis Market" report